A new study published in JAMA found neladenoson bialanate did not improve exercise capacity among patients suffering from heart failure with preserved ejection fraction.
Browsing: Clinical Breakthroughs
A drug called tanezumab reduced pain and improved physical function in patients with osteoarthritis, although more research on safety is needed, according to a study published in JAMA.
Daily vitamin D supplements did not significantly reduce the risk of Type 2 diabetes among adults at high risk for the disease, according to a large clinical trial published in The New England Journal of Medicine.
Gentle sound stimulation played during deep sleep enhanced deep or slow-wave sleep for people with mild cognitive impairment, who are at risk for Alzheimer’s disease, according to a Northwestern Medicine study.
Restricting physicians’ ability to view multiple patient records at the same time did not reduce wrong-patient orders, according to a large clinical trial published in JAMA.
A targeted intervention to support asthma self-management significantly improved outcomes and medication adherence among older adults with asthma, according to a new study published in JAMA Internal Medicine.
More than 80 percent of antibiotics prescribed before dental procedures to prevent infection are unnecessary, according to a study published in JAMA Network Open.
In a surprising new finding, radiation combined with chemotherapy did not increase recurrence-free survival in women with stage III/IVA endometrial cancer following surgery.
Many patients with mild asthma may not benefit from inhaled steroid medications, the current standard treatment, according to a clinical trial published in the New England Journal of Medicine.
A combination of idelalisib and rituximab is an effective and safe treatment for patients with relapsed chronic lymphocytic leukemia, according to the results of a phase III clinical trial.